Skip to content

SPROTECH

Active
Public limited companyfounded 1986active for 40 yearsIndustriepark-West 49, 9100 Sint-Niklaas, BelgiumKBO/BCE: BE 0428.819.182
Summary

The annual accounts of SPROTECH for financial year 2025 show a net loss of 81% of total assets and of 91% of the equity at the start of that year. The 2025 annual accounts show equity of €283,338 and a net result of -€2.7m. Equity remains stable across the filed financial years (±1.1% per year). Its solvency ranks better than 12% of 6,152 sector peers (NACE 46, financial year 2025). The company has been active since 1986 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.7% (low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460Manufacture of medical and dental instruments and supplies NACE 32500
1 site
Size
≈ €750,000turnover 2025, estimated
Staff
2 FTE
Equity
€283,338
Loss
-€2.7m
Turnover estimated from the gross margin
Financial health
53 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.7%
Structure
Holdings
1
  • SPRONKENDirector · permanent representative SPRONKEN Maria Leonardina Antonia Elisabeth
  • SPRONKEN GROUPDirector · permanent representative SPRONKEN HOEYBERGHS Caius Leonard
2025 accounts filed 25 days late2 of 9 deeds summarised
Why 53raises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearLoss of €2.7m (financial year 2025)Equity €283,338 (8.4% of total assets)lowers riskSize: total assets €3.4mFigures for financial year 2025 (filed 28-08-2026)Show the evidence

Checked score

Score 2025
53 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 21% of its sector peers (NACE 46, small)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 33-42
equity 8.4% of total assets
Liquidity 50=
short-term debt 19.3% · cash 4.6%
Profitability 14-46
return on assets -80.8%
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%

About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,374 companies, NACE 46, small)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.2 percentage points vs 07-2026 09-2026: 0.7%▲ +0.4 percentage points vs 08-2026highest value 10-2026: 0.7%● unchanged vs 09-2026
Credit of up to €15,000 on 30-day terms, only on tighter conditions
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity insufficient (current ratio 0.65, compared with 0.46 in 2024, below 1; short-term debt: 19.3% and cash: 4.6% of total assets), and 91.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small): better than 11% on solvency, 61% on liquidity, 9% on profitability and 2% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Loss of €2.7m (financial year 2025)
NBB · annual accounts
lowers risk · Size: total assets €3.4m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €283,338 (8.4% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 28-08-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 12% of 6152 sector peers (2025).
NBB · sector comparison
Position among 6152 sector peers
Solvency
better than 12%
← weakest strongest →
raises risk · 2025 accounts filed 25 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-08-2026, 25 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
25 days late
2024
13 days early
2023
40 days late
2022
21 days late
2021
38 days early
2020
27 days late
2019
102 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 23 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 21 August (4 of the last 5 filed years within 34 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Weakest financial yearnet -€2.7m
  3. Reappointments: SPRONKEN (director) and SPRONKEN GROUP…Permanent representatives: SPRONKEN Maria Leonardina…

Financials · financial year 2025, full format

2025 annual accounts filed late (25 days) Filed on 25 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00439146.

Turnover
≈ €750,000
Estimated: probably between €470,000 and €1.1m
EBIT margin
Not included in this filing
Net result
-€2.7m
2024 · €2.0m
Working capital
-€227,926▲ 36.5%
2024 · -€359,120
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result recovers in 2025; 2025 is 27% above 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.02m 2025 Net result-€2.7m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result-€0.04m-€0.06m€0.01m▼ 76.7%€0.03m▲ 100%€0.05m▲ 64.0%€0.06m▲ 33.8%€0.01m▼ 78.4%€0.02m▲ 27.1%
Net result-€0.05m-€0.06m€0.01mwithin the sector's middle half▼ 82.2%€0.02mwithin the sector's middle half▲ 78.9%-€0.02mbelow the sector's middle half€0.01mwithin the sector's middle half€2.0mabove the sector's middle half▲ 160×-€2.7mbelow the sector's middle half
Equity€1.0m-€1.0m▲ 5.9%€1.0mabove the sector's middle half▲ 1.0%€1.0mwithin the sector's middle half▲ 1.7%€1.0mwithin the sector's middle half▼ 1.5%€1.0mwithin the sector's middle half▲ 1.2%€3.0mabove the sector's middle half▲ 189%€0.3mbelow the sector's middle half▼ 90.6%
Total assets€1.7m-€1.7m▼ 4.6%€1.7mabove the sector's middle half▲ 1.5%€4.4mabove the sector's middle half▲ 163%€3.6mabove the sector's middle half▼ 19.1%€3.6mabove the sector's middle half▲ 1.3%€6.0mabove the sector's middle half▲ 66.2%€3.4mwithin the sector's middle half▼ 44.2%
Debt€0.8m-€0.6m▼ 17.6%€0.7m▲ 2.4%€3.4m▲ 417%€2.6m▼ 24.6%€2.6m▲ 1.3%€3.0m▲ 16.9%€3.1m▲ 1.9%
Working capital-€0.6m--€0.5m▲ 16.8%-€0.4mbelow the sector's middle half▲ 16.9%-€0.6mbelow the sector's middle half▼ 57.0%-€0.5mbelow the sector's middle half▲ 23.4%-€0.3mbelow the sector's middle half▲ 36.2%-€0.4mbelow the sector's middle half▼ 20.2%-€0.2mbelow the sector's middle half▲ 36.5%
Solvency55.3%-61.4%▲ 6.1pp61.0%within the sector's middle half▼ 0.3pp23.6%within the sector's middle half▼ 37.5pp28.7%within the sector's middle half▲ 5.2pp28.7%within the sector's middle half=49.8%within the sector's middle half▲ 21.1pp8.4%below the sector's middle half▼ 41.4pp
Current ratio0.17-0.23▲ 0.060.38below the sector's middle half▲ 0.150.82below the sector's middle half▲ 0.440.81below the sector's middle half▼ 0.010.88below the sector's middle half▲ 0.070.46below the sector's middle half▼ 0.420.65below the sector's middle half▲ 0.19
Return on assets (ROA)-2.6%-3.4%▲ 6.0pp0.6%within the sector's middle half▼ 2.8pp0.4%below the sector's middle half▼ 0.2pp-0.4%below the sector's middle half▼ 0.8pp0.3%within the sector's middle half▲ 0.8pp32.6%above the sector's middle half▲ 32.2pp-80.8%below the sector's middle half▼ 113.4pp
Staff (FTE)2.2-0.7▼ 68.2%2.5above the sector's middle half▲ 257%2.9within the sector's middle half▲ 16.0%2.9within the sector's middle half=2.4within the sector's middle half▼ 17.2%2within the sector's middle half▼ 16.7%2below the sector's middle half=
above within below the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.4m
Fixed assets €2.9m ▼ 48.5%
Current assets €422,042 ▲ 37.4%
Equity and liabilities €3.4m
Equity €283,338 ▼ 90.6%
Debt €3.1m ▲ 1.9%
Debt's share of the balance-sheet total rises from 50.2% to 91.6%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€122,270▲
2024 · €119,427
Cash flow
-€2.6m▼
2024 · €2.1m
Debt to equity
10.87▲
2024 · 1.01
ROE
-959.7%▼
2024 · 65.4%
Interest coverage
1.70▲
2024 · 1.26
Debt ≤ 1 year
€649,968▼
2024 · €666,250
Debt > 1 year
€2.4m▲
2024 · €2.3m
Staff costs
€552▼
2024 · €1,762
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 540 companies that looked in July 2024 the way this one looks now, 5.2% went bankrupt within 24 months and 85.9% are still going.

  • Micro
  • 20 years or older
  • solvency under 10%
  • a loss of 10% of the balance sheet or more
5.2% went bankrupt
8.3% stopped otherwise
85.9% still going

A further 0.6% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.7% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 540 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 49 lines
Balance sheet Code20242025
Assets
Total assets20/58€6.0m€3.4m▼
Fixed assets21/28€5.7m€2.9m▼
Tangible fixed assets22/27€1.4m€1.3m▼
Land and buildings22€1.4m€1.3m▼
Financial fixed assets28€4.3m€1.7m▼
Current assets29/58€0.3m€0.4m▲
Amounts receivable after more than one year29€0.07m€0.07m=
Other amounts receivable291€0.07m€0.07m=
Amounts receivable within one year40/41€0.2m€0.2m▼
Other amounts receivable41€0.2m€0.2m▼
Cash at bank and in hand54/58€0.03m€0.2m▲
Deferred charges and accrued income490/1€0.007m€0.006m▼
Equity and liabilities
Total equity and liabilities10/49€6.0m€3.4m▼
Equity10/15€3.0m€0.3m▼
Contributions10/11€0.5m€0.5m=
Capital10€0.5m€0.5m=
Issued capital100€0.5m€0.5m=
Reserves13€2.5m€0.05m▼
Non-distributable reserves130/1€0.05m€0.05m=
Legal reserve130€0.05m€0.05m=
Distributable reserves133€2.5m-
Profit (loss) carried forward14--€0.2m
Amounts payable17/49€3.0m€3.1m▲
Amounts payable after more than one year17€2.3m€2.4m▲
Financial debts170/4€2.3m€2.4m▲
Amounts payable within one year42/48€0.7m€0.6m▼
Trade debts44€0.02m€0.03m▲
Suppliers440/4€0.02m€0.03m▲
Other amounts payable47/48€0.6m€0.6m▼
Accrued charges and deferred income492/3€0.008m-
Income statement Code20242025
Remuneration, social security and pensions62€0.002m€0.001m▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.1m€0.1m▼
Other operating charges640/8€0.08m€0.06m▼
Non-recurring operating charges66A€0.001m-
Gross operating margin9900€0.2m€0.2m▼
Operating profit (loss)9901€0.01m€0.02m▲
Financial income75/76B€2.0m€0.006m▼
Recurring financial income75€2.0m€0.006m▼
Financial charges65/66B€0.1m€2.7m▲
Recurring financial charges65€0.1m€0.07m▼
Non-recurring financial charges66B-€2.7m
Profit (loss) for the period before taxes9903€2.0m-€2.7m▼
Profit (loss) for the period9904€2.0m-€2.7m▼
Profit (loss) for the period to be appropriated9905€2.0m-€2.7m▼
Appropriation of the result
Profit (loss) to be appropriated9906€2.0m-€2.7m▼
Transfer from equity791/2-€2.5m
Transfer to equity691/2€2.0m-
To other reserves6921€2.0m-
Social balance sheet
Average headcount (FTE)90872.02.0=

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Remuneration, social security and pensions62---€0.08m€0.06m€0.02m€0.002m€0.001m▼ 68.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.1m€0.1m€0.1m€0.1m€0.1m€0.1m€0.1m€0.1m▼ 0.8%
Other operating charges640/8---€0.03m€0.03m€0.04m€0.08m€0.06m▼ 19.3%
Non-recurring operating charges66A----€219-€0.001m--
Gross operating margin9900€0.2m€0.2m€0.2m€0.3m€0.2m€0.2m€0.2m€0.2m▼ 7.0%
Operating profit (loss)9901-€0.04m€0.06m€0.01m€0.03m€0.05m€0.06m€0.01m€0.02m▲ 27.1%
Financial income75/76B---€1€45€18€2.0m€0.006m▼ 99.7%
Recurring financial income75€0€182-€1€45€18€2.0m€0.006m▼ 99.7%
Financial charges65/66B---€0.004m€0.06m€0.05m€0.1m€2.7m▲ 29×
Recurring financial charges65€422€310€0.001m€0.004m€0.06m€0.05m€0.1m€0.07m▼ 24.2%
Non-recurring financial charges66B-------€2.7m-
Profit (loss) for the period before taxes9903-€0.05m€0.06m€0.01m€0.02m-€0.02m€0.01m€2.0m-€2.7m-
Income taxes67/77-€0.006m€0.004m€0.007m-----
Profit (loss) for the period9904-€0.05m€0.06m€0.01m€0.02m-€0.02m€0.01m€2.0m-€2.7m-
Profit (loss) for the period to be appropriated9905-€0.05m€0.06m€0.01m€0.02m-€0.02m€0.01m€2.0m-€2.7m-
Line20182019202020212022202320242025Change
Assets
Total assets20/58€1.7m€1.7m€1.7m€4.4m€3.6m€3.6m€6.0m€3.4m▼ 44.2%
Fixed assets21/28€1.6m€1.5m€1.4m€1.7m€1.6m€1.4m€5.7m€2.9m▼ 48.5%
Tangible fixed assets22/27€1.6m€1.5m€1.4m€1.7m€1.6m€1.4m€1.4m€1.3m▼ 7.7%
Land and buildings22---€1.7m€1.6m€1.4m€1.4m€1.3m▼ 7.7%
Financial fixed assets28€0.002m€0.002m€0.002m€0.002m€0.002m-€4.3m€1.7m▼ 61.4%
Current assets29/58€0.1m€0.1m€0.2m€2.8m€2.0m€2.2m€0.3m€0.4m▲ 37.4%
Amounts receivable after more than one year29------€0.07m€0.07m=
Other amounts receivable291------€0.07m€0.07m=
Stocks and contracts in progress3€0.01m--------
Amounts receivable within one year40/41€0.01m€0.03m€0.04m€0.01m€0.008m€0.01m€0.2m€0.2m▼ 3.1%
Trade receivables40---€0.01m€0.002m€0.001m---
Other amounts receivable41---€0.001m€0.006m€0.01m€0.2m€0.2m▼ 3.1%
Current investments50/53-----€2.0m---
Cash at bank and in hand54/58€0.09m€0.1m€0.2m€2.8m€2.0m€0.2m€0.03m€0.2m▲ 376%
Deferred charges and accrued income490/1---€0.006m€25€238€0.007m€0.006m▼ 10.5%
Equity and liabilities
Total equity and liabilities10/49€1.7m€1.7m€1.7m€4.4m€3.6m€3.6m€6.0m€3.4m▼ 44.2%
Equity10/15€1.0m€1.0m€1.0m€1.0m€1.0m€1.0m€3.0m€0.3m▼ 90.6%
Contributions10/11€0.5m€0.5m€0.5m€0.5m€0.5m€0.5m€0.5m€0.5m=
Capital10---€0.5m€0.5m€0.5m€0.5m€0.5m=
Issued capital100---€0.5m€0.5m€0.5m€0.5m€0.5m=
Reserves13€0.5m€0.6m€0.6m€0.6m€0.6m€0.6m€2.5m€0.05m▼ 98.2%
Non-distributable reserves130/1---€0.05m€0.05m€0.05m€0.05m€0.05m=
Legal reserve130---€0.05m€0.05m€0.05m€0.05m€0.05m=
Distributable reserves133---€0.5m€0.5m€0.5m€2.5m--
Profit (loss) carried forward14--------€0.2m-
Amounts payable17/49€0.8m€0.6m€0.7m€3.4m€2.6m€2.6m€3.0m€3.1m▲ 1.9%
Amounts payable after more than one year17------€2.3m€2.4m▲ 3.5%
Financial debts170/4------€2.3m€2.4m▲ 3.5%
Amounts payable within one year42/48€0.7m€0.6m€0.6m€3.4m€2.5m€2.5m€0.7m€0.6m▼ 2.4%
Trade debts44€0.007m€0.001m€0.009m€0.02m€0.002m€0.002m€0.02m€0.03m▲ 74.4%
Suppliers440/4---€0.02m€0.002m€0.002m€0.02m€0.03m▲ 74.4%
Taxes, remuneration and social security45---€0.02m€0.02m----
Taxes450/3---€0.007m€0.009m----
Remuneration and social security454/9---€0.009m€0.008m----
Other amounts payable47/48---€3.3m€2.5m€2.5m€0.6m€0.6m▼ 4.6%
Accrued charges and deferred income492/3---€0.003m€0.06m€0.1m€0.008m--
Line20182019202020212022202320242025Change
Profit (loss) for the period9904-€0.05m€0.06m€0.01m€0.02m-€0.02m€0.01m€2.0m-€2.7m-
+ Depreciation and write-downs630€0.1m€0.1m€0.1m€0.1m€0.1m€0.1m€0.1m€0.1m▼ 0.8%
Operating cash flow (approximation)€0.09m€0.2m€0.1m€0.1m€0.09m€0.1m€2.1m-€2.6m-
Investment in fixed assets (approximation)-€0-€0.03m-€0.3m€0€0.002m-€4.4m€2.7m-
Change in cash-€0.02m€0.09m€2.6m-€0.7m-€1.9m-€0.1m€0.1m-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 39 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 full format 25-08-2026 2026-00439146
31-12-2024 abbreviated format 18-07-2025 2025-00305100
31-12-2023 abbreviated format 09-09-2024 2024-00459433
31-12-2022 abbreviated format 21-08-2023 2023-00370317
31-12-2021 abbreviated format 23-06-2022 2022-20086026
31-12-2020 micro format 27-08-2021 2021-55400370
31-12-2019 micro format 10-11-2020 2020-70000257
31-12-2018 micro format 20-08-2019 2019-48200134
31-12-2017 micro format 28-08-2018 2018-52200163
31-12-2016 micro format 31-08-2017 2017-56100176

Show all 39 filings

Similar companies · same sector, comparable size

Of the 1,866 active companies whose main activity is wholesale of pharmaceutical and medical goods (NACE 46460), figures are known for 1,130. 723 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
2 directors, last change in 2025

Board 2

SPRONKEN
Director · since 25-06-2025 · Private limited company · permanent representative: SPRONKEN Maria Leonardina Antonia Elisabeth
Current
SPRONKEN GROUP
Director · since 25-06-2025 · Public limited company · permanent representative: SPRONKEN HOEYBERGHS Caius Leonard
Current

Permanent representatives 2

SPRONKEN HOEYBERGHS Caius Leonard
Permanent representative · since 25-06-2025 · for SPRONKEN GROUP
Current
SPRONKEN Maria Leonardina Antonia Elisabeth
Permanent representative · since 25-06-2025 · for SPRONKEN
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
7 of this company's 9 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

4 people since 2025, 2 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
SPRONKEN
  • Director, from 25-06-2025 to date
SPRONKEN GROUP
  • Director, from 25-06-2025 to date
Caius Spronken
  • Director, until 25-06-2025
Raccea Spronken
  • Director, until 25-06-2025
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Capital over the years
  1. 31-12-2025 Capital stated in the deed · €457,500 · 514 shares

Group and network

Holdings and subsidiaries

1 holding

Holdings 1

  • Spronken Orthopedie NederlandNLsubsidiary
    Equity €1.7mResult -€103,809
    100%

According to the 2025 annual accounts of SPROTECH and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Connections & network

5 connected companies
Linked via shared directors
I'MMSPRO
Shared corporate director
→
ORTHO MEDICA
Shared corporate director
→
QUALITY PRODUCTION
Shared corporate director
→
Show 1 more companies with a shared director
SPRONKEN ORTHOPEDIE
Shared corporate director
→

History

SPROTECH was incorporated on 21 March 1986.1 Total assets rose from €1.7m in 2018 to €3.4m in 2025 and headcount from 2.2 to 2 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
25-08
NBB filing Annual accounts filed
financial year 2025 · full format · 25 days late
2025
31-12
Financial Weakest financial yearnet -€2.7m
Net result drops to -€2.7m, the lowest in the series.
31-12
Gazette deed Reappointments: SPRONKEN (director) and SPRONKEN GROUP (director)
Permanent representatives: SPRONKEN Maria Leonardina Antonia Elisabeth and SPRONKEN HOEYBERGHS Caius Leonard · Amendment of the articles · Purpose change11 facts ▸
  • General meeting, 18-12-2025
  • Amendment of the articles (2 times)
  • Other provision, “vrijstelling voorlezing verslag en goedkeuring voorstel wijziging voorwerp, algemene vergadering ontslaat voorzitter van voorlezing” (deed in Dutch)
  • Purpose change
  • Capital, €457,500
  • General meeting, “collegiaal bestuur” (deed in Dutch)
  • Director reappointment, SPRONKEN (director)
  • Permanent representative, SPRONKEN Maria Leonardina Antonia Elisabeth
  • Director reappointment, SPRONKEN GROUP (director)
  • Permanent representative, SPRONKEN HOEYBERGHS Caius Leonard
  • Registered office clause, “Vlaamse Gewest, 9100 Sint-Niklaas,Industriepark-West 49” (deed in Dutch)
04-08
Gazette deed Resignations: Caius Spronken (director) and Raccea Spronken (director)
Appointments: Spronken BV (director) and Spronken Group NV (director) · Permanent representatives: Maria Spronken and Caius Spronken8 facts ▸
  • General meeting, 25-06-2025
  • Director resignation, Caius Spronken (director)
  • Director resignation, Raccea Spronken (director)
  • Director appointment, Spronken BV (director)
  • Permanent representative, Maria Spronken (representative)
  • Director appointment, Spronken Group NV (director)
  • Permanent representative, Caius Spronken (representative)
  • Other provision, “bestuursverbod, niet getroffen te zijn door enige verbodsbepaling” (deed in Dutch)
18-07
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
2024
31-12
Financial Highest result from 2018 to 2025net €2.0m ▲15,887%
Net result €2.0m, the highest in the series.
31-12
Financial Equity above €2mequity €3.0m ▲189%
2 profitable years in a row build equity to €3.0m.
09-09
NBB filing Annual accounts filed
financial year 2023 · abbreviated format · 40 days late
2023
31-12
Financial Back to profitnet €12,275
Net result €12,275 after one loss-making year.
21-08
NBB filing Annual accounts filed
financial year 2022 · abbreviated format · 21 days late
2022
23-06
NBB filing Annual accounts filed
financial year 2021 · abbreviated format
2021
27-08
NBB filing Annual accounts filed
financial year 2020 · micro format · 27 days late
Show earlier events
2020
10-11
NBB filing Annual accounts filed
financial year 2019 · micro format · 102 days late
2019
31-12
Financial Back to profitnet €56,352
Net result €56,352 after one loss-making year.
31-12
Financial Equity above €1mequity €1.0m ▲5.9%
Equity rises from €958,952 to €1.0m.
20-08
NBB filing Annual accounts filed
financial year 2018 · micro format · 20 days late
2018
28-08
NBB filing Annual accounts filed
financial year 2017 · micro format · 28 days late
2017
31-08
NBB filing Annual accounts filed
financial year 2016 · micro format · 31 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 39 annual accounts filed, the latest 10 are here; all 39 are under Financials.
2 of 9 deeds read
About the unread acts

Of the 9 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 7 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPublic limited company
Founded21-03-1986
Financial year end31-12
Activities, NACEBEL 2025
32500Manufacture of medical and dental instruments and supplies
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
E-invoicing
Reachable via Peppol
Peppol ID 0208:0428819182
Registered 16-01-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Sint-Niklaas · 1 establishment unit since 1992
registered office establishment The establishment unit on the map
Ground area
3,798 m²
Building footprint
1,843 m²
Building volume
11,946 m³
2 parcels, Flanders · tallest building 29.2 m. Linked by address, not a title deed.
1 establishment unit
IMSPRO
Grotestraat 46, 3600 GenkManufacture of medical and dental instruments and supplies
since 1992unit no. 2.037.303.470
2 parcels
Flanders 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
46445D1829/00Y000 Flanders 3,021 m² 1 · 1,295 m² 29.2 m · 2
71016I0847/00H000 Flanders 777 m² 1 · 548 m² 15.9 m · 3
How the parcels are linked
Good to know
Both parcels match the address exactly.

Articles of association

What the company does

Name clauseThe name the company operates under according to its articles.
SPROTECH
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaams Gewest” (deed in Dutch)

deed of 31-12-2025

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
5 provisions in the deed
Power of attorneyA special mandate allowing someone to perform one or more acts on the company's behalf.
One provision in the deed

deed of 31-12-2025

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
One provision in the deed

deed of 31-12-2025

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Third Tuesday of June at 16:00

deed of 31-12-2025

Oversight and winding up

Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Enige vereffenaar of elke vereffenaar individueel handelend zo er meerderen zijn, alle handelingen die nodig of dienstig zijn voor de…” (deed in Dutch)

deed of 31-12-2025

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Door de vennootschap ter beschikking gesteld elektronisch communicatiemiddel, elektronische algemene vergadering” (deed in Dutch)
Other provision: “Stemrecht, gewone meerderheid van stemmen” (deed in Dutch)
Other provision: “Elke algemene vergadering,zowel de jaarlijkse als de buitengewone en de bijzondere, verdaging van de algemene vergadering” (deed in Dutch)
Other provision: “Bestemming van de winst-uitkeringen, algemene vergadering” (deed in Dutch)
Other provision: “Uitkering van dividenden en interim-dividenden, op eigen verantwoordelijkheid en overeenkomstig de wettelijke bepalingen uit het resultaat…” (deed in Dutch)
Other provision: “Verboden uitkeringen, elke uitkering in strijd met het vermelde in voorgaande artikelen” (deed in Dutch)
Other provision: “Mits naleving van de wettelijke voorschriften en vormvereisten, in een vennootschap van een andere rechtsvorm” (deed in Dutch)
7 more provisions in the deed, see the deed of 31-12-2025

deed of 31-12-2025